NCT00528814
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +8 more
- Locations
-
- University of Alabama at Birmingham, Lung Health Center Birmingham, Alabama, United States
Clinical trial condition
Bronchial Diseases
Explore clinical trials studying Bronchial Diseases. Study availability and eligibility vary by location and protocol.
4,808 public trials
452 recruiting studies
Bronchial Diseases trial results
NCT03273127
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Research Site Berlin, Germany
NCT03349138
- Conditions
- Brain Diseases, Bronchial Diseases, Bronchiolitis, +15 more
- Locations
-
- Villa Beretta Rehabilitation Center Costa Masnaga, Lecco, Italy
NCT01547286
- Conditions
- Asthma, Atopy, Bronchial Diseases, +7 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00967720
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
Completed
Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma
NCT01210170
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Human Research Laboratory- University of Miami School of Medicine Miami, Florida, United States
NCT00986037
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
Completed
Using HFNC in Bronchiolitis
NCT03342781
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchitis, +8 more
- Locations
-
Not specified
Completed
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
NCT01447459
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Norton Children's Hospital Louisville, Kentucky, United States
Completed
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
NCT02502734
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Randers, Denmark